Nezam El-Tayebat Fact CheckA scientific assessment of the “نظام الطيبات” nutrition system
Choose country
Choose language: English

Potentially true Overinterpreted Certainty of evidence: low provisional C-UPF-05

Higher ultra-processed food intake raises the risk of inflammatory bowel disease (PURE study: HR 1.82 for >=5 servings/day).

In short: This claim is possibly true for Crohn's disease: several large cohorts link high ultra-processed food intake to about 70% more Crohn's disease, but not to ulcerative colitis, and the absolute risk stays low; a causal effect is not proven.
Conclusion: Possibly true for Crohn's disease, which is consistently linked to high UPF intake in large cohorts; no link with ulcerative colitis, and causation is unproven.
  1. Original statement
  2. Scientific assessment
  3. Scientific evidence in detail
  4. In plain language
  5. Studies on this claim
  6. Regional context
  7. What applies in my country?
  8. References

Original statement

ارتبط استهلاك خمس حصص يومياً أو أكثر من الأطعمة فائقة المعالجة بخطر أعلى لأمراض الأمعاء الالتهابية (HR 1.82)

verbatim according to source. Translation by the project; the Arabic wording is authoritative.

Translation

Higher ultra-processed food intake raises the risk of inflammatory bowel disease (PURE study: HR 1.82 for >=5 servings/day).

Origin

Source status
Archive editors
Attribution
Archive editors (study selection and narrative are the archive's, not necessarily Elawady's)
Origin
https://eltayebat.com/rule/ultra-processed-foods/
Attribution uncertainty
The archive homepage states that the forbidden-food section is supported by research 'independently of Dr. Diaa's words'. No evidence was found that Elawady himself cited these studies.
Claimed mechanism

Emulsifiers, additives (hypothesised).

Claimed health effect

Crohn's disease, ulcerative colitis.

Population concerned

Adults 35-70, 21 countries

Geographic restriction by Elawady

none found

Scientific assessment

Potentially true – Some evidence points in favour of the statement, but it is not sufficient for a clear judgement.

Certainty of evidence: low – Further research is likely to change the assessment considerably.

1. What was claimed?

UPF raises IBD risk.

2. What is demonstrably correct?

Narula 2021 (A-UPF-12): HR 1.82 (1.22-2.72) for >=5 servings/day vs <1; soft drinks, refined sweetened foods, salty snacks and processed meat each associated.

3. What is wrong or exaggerated?

Absolute risk is low (467 cases among 116,087 over ~10 years); single cohort with low precision and risk of outcome misclassification; the ulcerative colitis association was not significant, and pooled evidence is weak for Crohn's disease and absent for ulcerative colitis (A-UPF-13).

4. What remains unclear?

Which components matter.

5. Which studies support it?

A-UPF-12 (PURE), Lo 2022 (I-UPF-111; Crohn's disease HR 1.70), Narula 2023 meta-analysis (I-UPF-110; Crohn's HR 1.71); A-UPF-15 (mechanism in mice).

6. Which studies contradict it?

No association with ulcerative colitis in pooled data (I-UPF-110, A-UPF-13); Vasseur 2021 (I-UPF-112) null but underpowered.

7. What applies to Germany and Europe?

Applies.

8. What is known about Egypt?

PURE included Middle Eastern sites; country-level results not reviewed.

9. What practical conclusion is appropriate?

Association noted; IBD is multifactorial.

Assessment details

Rationale for certainty of evidence

Several large cohorts and a meta-analysis of 5 cohorts associate high UPF intake with Crohn's disease (HR 1.71, 1.37-2.14; I-UPF-110; US cohorts HR 1.70, I-UPF-111; PURE A-UPF-12) but not with ulcerative colitis (HR 1.17, 0.86-1.61). A small French cohort (75 cases) found no association (I-UPF-112; underpowered). Observational; IBD remains rare; mechanistic support from animal studies.

Source quality

Accurately reported.

Regional transferability

Moderate; PURE included Europe, Middle East and other regions.

Individual exceptions

Not applicable.

Regional scope of the claim
general (biological/medical)
Last reviewed
26 October 2026 provisional

Scientific evidence in detail

Overinterpreted – A real finding exists, but the claim draws more from it than the data allow (e.g. association taken as cause, animal data applied to humans, small effect presented as large).

Research question: In adults, is higher UPF intake associated with higher incidence of inflammatory bowel disease (Crohn's disease and ulcerative colitis)?

Research question in detail (PECO)
Population
Adults
Intervention or exposure
Higher UPF intake
Comparison
Lower UPF intake
Geographic scope
universal biology
Outcomes
  • Crohn's disease
  • Ulcerative colitis

Study results as reported by the authors. Our assessment follows below.

What speaks for the claim?

What speaks against the claim?

What does the overall evidence say?

Editorial assessment based on the studies above – not itself a study result.

Which position is better supported?

UPF intake is consistently associated with Crohn's disease but not with ulcerative colitis.

Why some studies weigh more

Several large cohorts agree for CD; UC null.

Is a causal relationship established? Possible, not established Observational; mechanistic support from animals.

Remaining uncertainty

Causation; components.

Justified conclusion

The PURE figure is quoted correctly; 'IBD' should be narrowed to Crohn's disease, and causality is unproven.

Why do studies seem to disagree?

CD vs UC: different diseases; UC associations null or heterogeneous (I2 74%).

Does this depend on the country?
General biological effects
Biological mechanisms (energy density, eating rate, additives) are universal.
Eating habits
Mostly European and US diets studied; Egyptian UPF intake not quantified in the literature found (PubMed search: 2 hits, neither relevant).
Origin of the food
Not relevant.
Contaminants
Not relevant.
National production conditions
Product formulations differ by country.
Legal rules
No legal UPF category in EU or (as far as checked) Egypt.
Actual monitoring data
No Egyptian monitoring data.

A regional difference that changes the conclusion is not supported by robust data.

Statistical re-check
  • Power – 75 events -> minimum detectable HR about 1.9; null is weak evidence. recalculated
  • Incidence – CD 6.7 per 100,000 person-years. recalculated
Certainty of the overall evidence (GRADE, simplified)
Main outcome
Crohn's disease with UPF
Starting level
low (observational studies)
Reasons for downgrading
  • risk of bias (confounding)
Reasons for upgrading
  • consistency across cohorts
Result
low

Simplified assessment by a single reviewer, following the GRADE approach; not a formal GRADE panel. GRADE rates the body of evidence for one outcome, not individual studies.

Search strategy

Documented literature searches for this review (search strings in the original database syntax).

DatabaseDateSearchLooking forHitsIncluded
Europe PMC26 October 2026("ultra-processed" OR "ultraprocessed" OR "food processing") AND ("inflammatory bowel disease" OR "Crohn" OR "ulcerative colitis") AND (PUB_TYPE:"Meta-Analysis" OR TITLE:cohort OR TITLE:prospective) AND PUB_YEAR:[2021 TO 2026]both directions93

How deeply was this checked?

6 linked studies: 3 checked in full text (3 of them with a structured risk-of-bias assessment), 3 on the basis of the abstract, 0 bibliographically only. No formal assessment with two independent reviewers and no independent human expert review has taken place yet.

Last scientific review: 26 October 2026

History of the verdict
  1. 25 October 2026 · Phase 1 · Initial assessment: Potentially true (low)
  2. 26 October 2026 · Phase 4 (systematic evidence review) · Re-examined with extended evidence; verdict unchanged: Potentially true (low)
    Pooled evidence replicates the Crohn's association but not UC; verdict unchanged; wording sharpened.
    New sources: I-UPF-110 I-UPF-111 I-UPF-112

In plain language

A large study across 21 countries found more inflammatory bowel disease among people eating the most ultra-processed food. The disease remained rare overall. The finding needs confirmation.

Studies on this claim

Studies supporting the claim (2)

  • Ultra-processed food and inflammatory bowel disease in 21 countries

    Narula N et al.. BMJ 2021 · PMID 34261638 · DOI 10.1136/bmj.n1554
    Cohort studycited by the Tayebat archivefull text, structured risk-of-bias assessment★ key study

    Five or more servings a day: 82% higher IBD risk; legumes, dairy and vegetables showed no link.

    Also found no association of dairy, legumes, fruit and vegetables with IBD (relevant to other system rules).

    Does the study support the specific claim? Yes · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Is UPF intake associated with IBD?

    How was the study done?

    Prospective multinational cohort (PURE), country-specific FFQs.

    How many people, animals or samples were studied?

    116,087; 467 IBD cases; Adults 35-70

    What was actually found?

    >=5 servings/day HR 1.82 (1.22-2.72); 1-4/day 1.67 (1.18-2.37); soft drinks, refined sweetened foods, salty snacks, processed meat each associated; meat, dairy, starch, fruit, vegetables, legumes not associated.

    How large was the observed effect?

    HR 1.82 (1.22-2.72)

    What do the results mean in everyday life?

    Association; IBD remains rare.

    What are the study's limitations?

    Only 467 cases; most diagnoses were self-reported and only about one in five checked against medical records; diet measured once; the higher risk was similar at 1-4 and at 5 or more servings per day.

    What does it say about Elawady's specific claim?

    Supports C-UPF-05.

    Do the results apply to Germany and Europe?

    Moderate.

    What can explicitly not be concluded from this study?

    It cannot prove that ultra-processed food causes IBD or which ingredient might be responsible.

    Scientific details →

  • Ultra-processed food and Crohn's disease in US health workers

    Lo CH et al.. Clin Gastroenterol Hepatol 2022 · PMID 34461300 · DOI 10.1016/j.cgh.2021.08.031
    Cohort studyindependent cross-checkabstract checked

    In 245,000 adults, the highest UPF eaters had 70% more Crohn's disease, but no more ulcerative colitis.

    CD HR 1.70 (1.23-2.35) highest vs lowest quartile; UC not associated.

    Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    To link UPF to Crohn's disease and colitis.

    How was the study done?

    Three US cohorts.

    How many people, animals or samples were studied?

    245,112 adults.

    What was actually found?

    More Crohn's disease; no link with ulcerative colitis.

    How large was the observed effect?

    CD HR 1.70.

    What do the results mean in everyday life?

    The rare disease Crohn's may be linked to UPF.

    What are the study's limitations?

    Observational.

    What does it say about Elawady's specific claim?

    Partly supports C-UPF-05.

    Do the results apply to Germany and Europe?

    Moderate.

    What can explicitly not be concluded from this study?

    Cannot prove causation.

    Scientific details →

Studies contradicting or limiting the claim (2)

  • Umbrella review: ultra-processed food and health

    Lane MM et al.. BMJ 2024 · PMID 38418082 · DOI 10.1136/bmj-2023-077310
    Systematic reviewcited by the Tayebat archivefull text, structured risk-of-bias assessment★ key study

    UPF was linked to 32 of 45 health outcomes; certainty was mostly low.

    Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    What is the credibility of associations between UPF and health outcomes?

    How was the study done?

    Umbrella review of 45 pooled analyses with credibility classes and GRADE.

    How many people, animals or samples were studied?

    45 pooled analyses; n=9,888,373; Pooled populations

    What was actually found?

    Class I: CVD mortality RR 1.50 (1.37-1.63; GRADE very low); T2D dose-response RR 1.12 (1.11-1.13; moderate); prevalent anxiety OR 1.48 (low); common mental disorders OR 1.53 (low). Class II: all-cause mortality RR 1.21 (low), heart-disease mortality HR 1.66 (low), T2D OR 1.40 (very low), depression HR 1.22 (low), sleep OR 1.41, wheezing RR 1.40, obesity OR 1.55 (low). GRADE overall: 22 low, 19 very low, 4 moderate.

    How large was the observed effect?

    CVD mortality RR 1.50; T2D 1.12 per dose

    What do the results mean in everyday life?

    Consistent links, low certainty.

    What are the study's limitations?

    All the studies behind it are observational; many results rest on only 2-4 studies; for most outcomes the certainty is low or very low; the mental-health results come mainly from one-time surveys that cannot show what came first.

    What does it say about Elawady's specific claim?

    Core summary for C-UPF-03 and C-UPF-04.

    Do the results apply to Germany and Europe?

    High.

    What can explicitly not be concluded from this study?

    Causation.

    Scientific details →

  • No link found in a short French study

    Vasseur P et al.. Inflamm Bowel Dis 2021 · PMID 32055825 · DOI 10.1093/ibd/izaa018
    Cohort studyindependent cross-checkabstract checked

    In a French cohort followed for about two years, ultra-processed food was not linked to IBD, but only 75 people developed the disease.

    No association in a French cohort, but only 75 cases.

    Does the study support the specific claim? No · Methodological quality: low · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    To link diet with IBD.

    How was the study done?

    Cohort study.

    How many people, animals or samples were studied?

    105,832 adults; 75 cases.

    What was actually found?

    No association.

    How large was the observed effect?

    Not given.

    What do the results mean in everyday life?

    Too small to rule out a link.

    What are the study's limitations?

    Low power; short.

    What does it say about Elawady's specific claim?

    Weakly contradicts C-UPF-05.

    Do the results apply to Germany and Europe?

    High.

    What can explicitly not be concluded from this study?

    Cannot show there is no link.

    Scientific details →

Studies with mixed or unclear results (2)

  • Emulsifiers and gut inflammation in mice

    Chassaing B et al.. Nature 2015 · PMID 25731162 · DOI 10.1038/nature14232
    Animal studycited by the Tayebat archivefull text, structured risk-of-bias assessment★ key study

    Two common emulsifiers caused gut inflammation and metabolic problems in mice.

    Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Do emulsifiers promote gut inflammation and metabolic syndrome via microbiota?

    How was the study done?

    Mouse experiments with emulsifiers, germ-free mice and faecal transplants.

    How many people, animals or samples were studied?

    Not stated; Wild-type and colitis-prone mice

    What was actually found?

    Emulsifiers induced low-grade inflammation and obesity/metabolic syndrome in wild-type mice and robust colitis in predisposed mice; microbiota encroachment; effects transferable via microbiota.

    How large was the observed effect?

    Not applicable

    What do the results mean in everyday life?

    Possible concern for humans, not proven.

    What are the study's limitations?

    Mouse study only; doses of 0.1-1% in all food or water; the researchers knew which mice got which treatment; some groups very small; only two emulsifiers tested.

    What does it say about Elawady's specific claim?

    Mechanistic basis for C-UPF-06 and C-UPF-05.

    Do the results apply to Germany and Europe?

    Moderate.

    What can explicitly not be concluded from this study?

    It cannot show that emulsifiers cause bowel inflammation or weight gain in humans, or at what human intake level any effect would occur.

    Scientific details →

  • Ultra-processed food and inflammatory bowel disease: pooled data

    Narula N et al.. Clin Gastroenterol Hepatol 2023 · PMID 36731590 · DOI 10.1016/j.cgh.2023.01.012
    Meta-analysisindependent cross-checkabstract checked

    Across five cohorts, high UPF intake was linked to 71% more Crohn's disease but not to ulcerative colitis.

    CD HR 1.71 (1.37-2.14); UC not associated (HR 1.17, 0.86-1.61).

    Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    To pool cohorts on UPF and IBD.

    How was the study done?

    Meta-analysis of 5 cohorts.

    How many people, animals or samples were studied?

    Over 1 million people.

    What was actually found?

    Crohn's disease associated; ulcerative colitis not.

    How large was the observed effect?

    CD HR 1.71 (1.37-2.14).

    What do the results mean in everyday life?

    The link concerns Crohn's disease specifically.

    What are the study's limitations?

    Few cohorts; observational.

    What does it say about Elawady's specific claim?

    Partly supports C-UPF-05.

    Do the results apply to Germany and Europe?

    Applicable.

    What can explicitly not be concluded from this study?

    Cannot prove causation.

    Scientific details →

Regional context

Germany / EU

Applies.

Egypt

PURE included Middle Eastern sites; country-level results not reviewed.

What applies in my country?

General scientific assessment

Potentially true Possibly true for Crohn's disease, which is consistently linked to high UPF intake in large cohorts; no link with ulcerative colitis, and causation is unproven.

The following areas of food safety are relevant to this statement:

  • Additives and processing
  • Controls, imports, recalls, labelling

Choose a country to see the checked information for it.

Limits: legal rules describe what is allowed, not what every single food contains. Measurement data come from samples and are meaningful only together with their method details.

Country of residence or purchase Compare with another country

References

  1. Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study.. Narula N et al.. BMJ 2021 · PMID 34261638 · DOI 10.1136/bmj.n1554
  2. Ultra-processed Foods and Risk of Crohn's Disease and Ulcerative Colitis: A Prospective Cohort Study.. Lo CH et al.. Clin Gastroenterol Hepatol 2022 · PMID 34461300 · DOI 10.1016/j.cgh.2021.08.031
  3. Ultra-processed food exposure and adverse health outcomes: umbrella review of epidemiological meta-analyses.. Lane MM et al.. BMJ 2024 · PMID 38418082 · DOI 10.1136/bmj-2023-077310
  4. Dietary Patterns, Ultra-processed Food, and the Risk of Inflammatory Bowel Diseases in the NutriNet-Santé Cohort.. Vasseur P et al.. Inflamm Bowel Dis 2021 · PMID 32055825 · DOI 10.1093/ibd/izaa018
  5. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome.. Chassaing B et al.. Nature 2015 · PMID 25731162 · DOI 10.1038/nature14232
  6. Food Processing and Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.. Narula N et al.. Clin Gastroenterol Hepatol 2023 · PMID 36731590 · DOI 10.1016/j.cgh.2023.01.012

← Back to overview